Incidence And Severity Of Suxamethonium Induced Fasciculation And Post-Operative Myalgia, And Their Association With Different Iv Induction Agents Among Adult Patients Underwent Elective Surgery At Jimma Medical Center, A Prospective Cohort Study

AbstractBackgroundCOVID-19 vaccine trials and post-implementation data suggest vaccination decreases SARS-CoV-2 infections. We examine COVID-19 vaccination’s impact on SARS-CoV-2 case rates and viral diversity among healthcare workers (HCW) during a high community prevalence period.MethodsA prospective cohort study from Boston Medical Center (BMC)’s HCW vaccination program, where staff received two doses of BNT162b2 or mRNA-1273. We included PCR-confirmed SARS-CoV-2 cases among HCWs from December 09, 2020 to February 23, 2021. Weekly SARS-CoV-2 rates per 100,000 person-day overall and by time from first injection (1-14 and >14 days) were compared with surrounding community rates. Viral genomes were sequenced from SARS CoV-2 positive samples.ResultsSARS-CoV-2 cases occurred in 1.4% (96/7109) of HCWs given at least a first dose and 0.3% (17/5913) of HCWs given both vaccine doses. Adjusted SARS-CoV-2 infection rate ratios were 0.73 (95% CI 0.53-1.00) 1-14 days and 0.18 (0.10-0.32) >14 days from first dose. HCW SARS-CoV-2 cases >14 days from initial dose compared to within 14 days were more often older (46 versus 38 years, p=0.007), Latinx (10% versus 8%, p=0.03), and asymptomatic (48% versus 11%, p=0.0002). SARS-CoV-2 rates among HCWs fell below those of the surrounding community, with a 18% versus 11% weekly decrease respectively (p=0.14). Comparison of 48 SARS-CoV-2 genomes sequenced from post-first dose cases did not indicate selection pressure towards known spike-antibody escape mutations.ConclusionsOur results indicate a positive impact of COVID-19 vaccines on SARS-CoV-2 case rates. Post-vaccination isolates did not show unusual genetic diversity or selection for mutations of concern.Main PointCases of SARS-CoV-2 among health care workers dropped rapidly with COVID-19 vaccination. Sequencing 48 breakthrough infections (overwhelmingly in 14 days after 1st dose) showed no clear sign of any differences in spike protein compared with time-matched, unvaccinated control sequences.

Download Full-text

Abstehende Ohren: Otoplastik wirkt sich positiv auf psychosoziale Probleme aus

Laryngo-Rhino-Otologie ◽

10.1055/a-0898-7732 ◽

2019 ◽

Vol 98 (09) ◽

pp. 603-604

Author(s):

Jörg Lindemann

Keyword(s):

Cohort Study ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Adult Patients ◽

Operative Korrektur ◽

Psychosocial Effects ◽

Psychosoziale Probleme

Sirin S et al. Psychosocial effects of otoplasty in adult patients: a prospective cohort study. Eur Arch Otorhinolaryngol 2019: 276: 1533–1539 Die operative Korrektur abstehender Ohren ist der häufigste ästhetische Eingriff im Alter unter 18 Jahren. Der psychosoziale Nutzen: Weniger Ängste, ein höheres Selbstwertgefühl und eine bessere Körperbildwahrnehmung. Ob Erwachsene gleichermaßen profitieren, ist bislang nur unzureichend untersucht. Eine Studie der türkischen Universität Kocaeli ist dieser Frage nachgegangen.

Download Full-text

Prognostic factors for outcomes of idiopathic sudden sensorineural hearing loss: protocol for the SeaSHeL national prospective cohort study

BMJ Open ◽

10.1136/bmjopen-2020-038552 ◽

2020 ◽

Vol 10 (9) ◽

pp. e038552

Author(s):

Rishi Mandavia ◽

Gerjon Hannink ◽

Muhammad Nayeem Ahmed ◽

Yaami Premakumar ◽

Timothy Shun Man Chu ◽

...

Keyword(s):

Hearing Loss ◽

Cohort Study ◽

Sensorineural Hearing Loss ◽

Prospective Cohort Study ◽

Health Research ◽

Prospective Cohort ◽

Prognostic Model ◽

Sudden Sensorineural Hearing Loss ◽

Sensorineural Hearing ◽

Adult Patients

IntroductionThe mainstay of treatment for idiopathic sudden sensorineural hearing loss (SSNHL) includes oral steroids, intratympanic steroid injections or a combination of both. The National Institute for Health and Care Excellence, in their recent hearing loss guidelines, highlighted the paucity of evidence assessing the comparative effectiveness of these treatments; and the National Institute for Health Research (NIHR) Health Technology Assessment Programme has since released a commissioned call for a trial to identify the most effective route of administration of steroids as a first-line treatment for idiopathic SSNHL. For such trials to be run effectively, reliable information is needed on patients with SSNHL: where they present, numbers, demographics, treatment pathways, as well as outcomes. This study will collect these data in a nationwide cohort study of patients presenting with SSNHL across 97 National Health Service (NHS) trusts. The study will be delivered through ear, nose and throat (ENT) trainee networks, the NIHR Clinical Research Network (CRN) Audiology Champions and the NIHR CRN. Importantly, this study will also provide a dataset to develop a prognostic model to predict recovery for patients with idiopathic SSNHL. The study objectives are to: (1) map the patient pathway and identify the characteristics of adult patients presenting to NHS ENT and hearing services with SSNHL, (2) develop a prognostic model to predict recovery for patients with idiopathic SSNHL and (3) establish the impact of idiopathic SSNHL on patients’ quality of life (QoL).Methods and analysisStudy design: national multicentre prospective cohort study across 97 NHS trusts.Inclusion criteria: adult patients presenting to NHS ENT and hearing services with SSNHL.Outcomes: change in auditory function; change in QoL score.Analysis: multivariable prognostic model, using prespecified candidate predictors. Mean change in QoL scores will be calculated from initial presentation to follow-up.Ethics and disseminationHealth Research Authority and NHS Research Ethics Committee approved the study. Publication will be on behalf of study sites and collaborators.Trial registration numberClinicalTrials.gov Registry (NCT04108598).

Download Full-text